Description
ASPREE is a completed randomised controlled trial of low-dose aspirin including 19,114 older adults free of cardiovascular disease, dementia and major physical disability at baseline. The trial started from 2010 and ended in June 2017. Since then, the trial participants continued to be followed up for additional 5 years till 2022. ASPREE is data and resource intensive which would be an ideal to study major age-related health outcomes in older adults.
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
Older, Ageing, Cardiovascular disease, Dementia, Cancer, Statin, Antihypertensives, Diabetes, Mortality, Primary prevention, cohort
School
School of Public Health and Preventive Medicine
Available options
PhD/Doctorate
Honours
Time commitment
Full-time
Top-up scholarship funding available
No
Physical location
553 St Kilda Rd, Melbourne (adjacent to The Alfred)